ABS-CBNNews.com, citing a Food and Drug Administration (FDA) advisory, reports that pharmaceutical company Pfizer is "voluntarily recalling its Robitussin DM cough syrup medicine due to errors in its labeling."
The report noted: "The products have discrepancies on both the primary label and carton regarding dosage instructions for children two (2) to six (6) years old." Apparently, as the advisory pointed out, "the wrong label states that dosage for the said age group is 2.5 mL or equivalent to 1 teaspoonful." In fact, the "correct dosage should have been 1/2 teaspoonful for every six (6) hours."
The advisory then asked "anyone who may have bought the affected products are advised to discontinue using the same and immediately coordinate" with Pfizer.
